SpaceX Faces Crucial Launch Test as IPO Speculation Intensifies Delivery Hero Shares Surge 10 as Uber Reportedly Revives Takeover Interest Qualcomm Faces Persistent Short Seller Pressure as AI Pivot Becomes Critical for Bulls Loop Capital Initiates American Express Coverage with Buy Rating Names Stock Top Pick Market Rotation Moving Beyond Blue Chips Thrive Capital Invests 100 Million in Shopify Betting on AIDriven Commerce Growth EH Q4 2025 Earnings Massive EPS Surprise as Profitability Arrives Unifi Inc Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Actions Begin to Take Hold DLR Q1 2026 Earnings Slight EPS Beat Amid Steady Data Center Demand CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates Amid Clinical Progress FLR Q1 2026 Earnings EPS Falls Sharply Short of Estimates Stock Edges Higher BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline DTE Energy Debenture DTB Holds Steady Near 17 as Bond Market Participants Seek Income VAALCO Energy EGY Slips 159 as Shares Test Key Support Near 542 Rocket Lab RKLB Slips 146 as Stock Consolidates Between Support and Resistance TPG Mortgage Investment Trust Inc MITT Gains Ground Above Key Support Prelude Therapeutics PRLD Climbs 3 as Bullish Momentum Builds Above Key Support Southeast Asias Biofuel Push Strains Food Supplies and Export Capacity Tenax Therapeutics Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Pipeline Progress Linkhome Holdings Inc LHAI Holds Steady at 090 as Key Levels Define Trading Range CFTC Prediction Market Oversight Insider Trading Crackdown and Regulatory Dispute Update How Maison Solutions MSS geographic mix shifted this quarter Q1 2026 Below Expectations The competitive moat visible in Arqit Quantum ARQQW earnings ARQQW Quarterly Earnings Arqit Quantum Warrants Lack Revenue EPS Data What Great Elm GECCG is doing to win in its industry GECCG Latest Quarter Earnings Great Elm posts stable 775 2030 note performance ZM Zoom Communications reports Q1 2026 EPS below estimates shares rise 224 as investors shrug off soft results Vertex Pharmaceuticals VRTX Poised for Material Upside as Lead IgA Nephropathy Asset Rides FastExpanding Rare Kidney Disease Market Why CurtissWright CW might be the portfolio Builder you need Mini Selloff 20260508